Various methods of gold nanoparticles (GNPs) conjugation to antibodies

Sensing and Bio-Sensing Research

Volumn 9, Issue , 2016, Pages 17-22

  Jazayeri, Mir Hadi ^a,b   Amani, Hamed ^a   Pourfatollah, Ali Akbar ^c   Pazoki Toroudi, Hamidreza ^d   Sedighimoghaddam, Bijan ^e  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bioconjugation; Chemical interaction; Gold nanoparticle; Noncovalent mode; Physical interaction covalent mode

Indexed keywords

EID: 84968813321     PISSN: None     EISSN: 22141804     Source Type: Journal    
DOI: 10.1016/j.sbsr.2016.04.002     Document Type: Review

References (71)

1. Ma X., Wu Y., Jin S., Tian Y., Zhang X., Zhao Y., et al. Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment. ACS Nano 2011, 5(11):8629-8639.
2. Gao J., Gu H., Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc. Chem. Res. 2009, 42(8):1097-1107.
3. Guo S., Huang Y., Jiang Q., Sun Y., Deng L., Liang Z., et al. Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. ACS Nano 2010, 4(9):5505-5511.
4. Kim D., Jeong Y.Y., Jon S. A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano 2010, 4(7):3689-3696.
5. Tiwari P.M., Vig K., Dennis V.A., Singh S.R. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 2011, 1(1):31-63.
6. Niikura K., Matsunaga T., Suzuki T., Kobayashi S., Yamaguchi H., Orba Y., et al. Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo. ACS Nano 2013, 7(5):3926-3938.
7. Nicol J.R., Dixon D., Coulter J.A. Gold nanoparticle surface functionalization: a necessary requirement in the development of novel nanotherapeutics. Nanomed.Nanotechnol. Biol. Med. 2015, 10(8):1315-1326.
8. Uchiyama M.K., Deda D.K., de Paula Rodrigues S.F., Drewes C.C., Bolonheis S.M., Kiyohara P.K., et al. In vivo and in vitro toxicity and anti-inflammatory properties of gold nanoparticle bioconjugates to the vascular system. Toxicol. Sci. 2014, 142(2):497-507.
9. Deng Z.J., Morton S.W., Ben-Akiva E., Dreaden E.C., Shopsowitz K.E., Hammond P.T. Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. ACS Nano 2013, 7(11):9571-9584.
10. 2/Si multilayers. ACS Nano 2009, 3(2):446-452.
11. Kumar A., Huo S., Zhang X., Liu J., Tan A., Li S., et al. Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum (IV) drug for prostate cancer treatment. ACS Nano 2014, 8(5):4205-4220.
12. Ijeh M. Covalent Gold Nanoparticle-Antibody Conjugates for Sensitivity Improvement in LFIA 2011, Hamburg University.
13. DeLong R.K., Reynolds C.M., Malcolm Y., Schaeffer A., Severs T., Wanekaya A. Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules. Nanotechnol. Sci. Appl. 2010, 3:53.
14. Chen J., Corbin I.R., Li H., Cao W., Glickson J.D., Zheng G. Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo. J. Am. Chem. Soc. 2007, 129(18):5798-5799.
15. Mu Q., Kievit F., Kant R., Lin G., Jeon M., Zhang M. Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells. Nanoscale 2015.
16. Song C., Zhong Y., Jiang X., Peng F., Lu Y., Ji X., et al. Peptide-conjugated fluorescent silicon nanoparticles enabling simultaneous tracking and specific destruction of cancer cells. Anal. Chem. 2015.
17. Meziani M.J., Sun Y.-P. Protein-conjugated nanoparticles from rapid expansion of supercritical fluid solution into aqueous solution. J. Am. Chem. Soc. 2003, 125(26):8015-8018.
18. Lemarchand C., Gref R., Couvreur P. Polysaccharide-decorated nanoparticles. Eur. J. Pharm. Biopharm. 2004, 58(2):327-341.
19. Fahmy T.M., Samstein R.M., Harness C.C., Saltzman W.M. Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomaterials 2005, 26(28):5727-5736.
20. Csáki A., Kaplanek P., Möller R., Fritzsche W. The optical detection of individual DNA-conjugated gold nanoparticle labels after metal enhancement. Nanotechnology 2003, 14(12):1262.
21. Dunn S.S., Tian S., Blake S., Wang J., Galloway A.L., Murphy A., et al. Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing. J. Am. Chem. Soc. 2012, 134(17):7423-7430.
22. Arruebo M., Valladares M., González-Fernández Á. Antibody-conjugated nanoparticles for biomedical applications. J. Nanomater. 2009, 2009:37.
23. Arosio D., Manzoni L., Araldi E.M., Scolastico C. Cyclic RGD functionalized gold nanoparticles for tumor targeting. Bioconjug. Chem. 2011, 22(4):664-672.
24. Sperling R.-A., Parak W. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos. Trans. R. Soc. Lond. A Math. Phys. Eng. Sci. 2010, 368(1915):1333-1383.
25. Sumbayev V.V., Yasinska I.M., Garcia C.P., Gilliland D., Lall G.S., Gibbs B.F., et al. Gold nanoparticles downregulate interleukin-1β-induced pro-inflammatory responses. Small 2013, 9(3):472-477.
26. Rosi N.L., Giljohann D.A., Thaxton C.S., Lytton-Jean A.K., Han M.S., Mirkin C.A. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 2006, 312(5776):1027-1030.
27. Saha K., Agasti S.S., Kim C., Li X., Rotello V.M. Gold nanoparticles in chemical and biological sensing. Chem. Rev. 2012, 112(5):2739-2779.
28. Pokharkar V., Bhumkar D., Suresh K., Shinde Y., Gairola S., Jadhav S. Gold nanoparticles as a potential carrier for transmucosal vaccine delivery. J. Biomed. Nanotechnol. 2011, 7(1):57-59.
29. Zhou X., Zhang X., Yu X., Zha X., Fu Q., Liu B., et al. The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine. Biomaterials 2008, 29(1):111-117.
30. Hall W.P., Ngatia S.N., Van Duyne R.P. LSPR biosensor signal enhancement using nanoparticle-antibody conjugates. J. Phys. Chem. C 2011, 115(5):1410-1414.
31. Zayats M., Baron R., Popov I., Willner I. Biocatalytic growth of Au nanoparticles: from mechanistic aspects to biosensors design. Nano Lett. 2005, 5(1):21-25.
32. Pissuwan D., Cortie C.H., Valenzuela S.M., Cortie M.B. Functionalised gold nanoparticles for controlling pathogenic bacteria. Trends Biotechnol. 2010, 28(4):207-213.
33. Pivodová V., Franková J., Galandáková A., Ulrichová J. In Vitro AuNPs' Cytotoxicity and Their Effect on Wound Healing 2015.
34. Meir R., Shamalov K., Betzer O., Motiei M., Horovitz-Fried M., Yehuda R., et al. Nanomedicine for cancer immunotherapy: tracking cancer-specific T-cells in vivo with gold nanoparticles and CT imaging. ACS Nano 2015, 9(6):6363-6372.
35. Wang F., Wang Y.-C., Dou S., Xiong M.-H., Sun T.-M., Wang J. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano 2011, 5(5):3679-3692.
36. Lin J., Zhang H., Chen Z., Zheng Y. Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship. ACS Nano 2010, 4(9):5421-5429.
37. Huang X., Jain P.K., El-Sayed I.H., El-Sayed M.A. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med. Sci. 2008, 23(3):217-228.
38. Frens G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature 1973, 241(105):20-22.
39. El-Sayed I.H., Huang X., El-Sayed M.A. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett. 2005, 5(5):829-834.
40. Rayavarapu R.G., Petersen W., Ungureanu C., Post J.N., van Leeuwen T.G., Manohar S. Synthesis and bioconjugation of gold nanoparticles as potential molecular probes for light-based imaging techniques. J. Biomed. Imaging 2007, 2007(1). (5-).
41. Barrientos Á G., de la Fuente J.M., Rojas T.C., Fernández A., Penadés S. Gold Glyconanoparticles: synthetic polyvalent ligands mimicking Glycocalyx-like surfaces as tools for Glycobiological studies. Chem. A Eur. J. 2003, 9(9):1909-1921.
42. Wang R., Zuo S., Wu D., Zhang J., Zhu W., Becker K.H., et al. Microplasma-assisted synthesis of colloidal gold nanoparticles and their use in the detection of cardiac troponin I (cTn-I). Plasma Process. Polym. 2015, 12(4):380-391.
43. Cao-Milán R., Liz-Marzán L.M. Gold nanoparticle conjugates: recent advances toward clinical applications. Expert Opin. Drug Deliv. 2014, 11(5):741-752.
44. Ljungblad J. Antibody-Conjugated Gold Nanoparticles Integrated in a Fluorescence Based Biochip 2009.
45. Kumar S., Aaron J., Sokolov K. Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties. Nat. Protoc. 2008, 3(2):314-320.
46. Zhang Z., Wang S., Xu H., Wang B., Yao C. Role of 5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer. J. Biomed. Opt. 2015, 20(5). (051043-).
47. Sokolov K., Follen M., Aaron J., Pavlova I., Malpica A., Lotan R., et al. Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res. 2003, 63(9):1999-2004.
48. Chen Z.-P., Peng Z.-F., Zhang P., Jin X.-F., Jiang J.-H., Zhang X.-B., et al. A sensitive immunosensor using colloidal gold as electrochemical label. Talanta 2007, 72(5):1800-1804.
49. Hermanson G. Bioconjugate Techniques 2008, Academic Press, London, UK. second ed.
50. Arkan E., Saber R., Karimi Z., Mostafaie A., Shamsipur M. Multiwall carbon nanotube-ionic liquid electrode modified with gold nanoparticles as a base for preparation of a novel impedimetric immunosensor for low level detection of human serum albumin in biological fluids. J. Pharm. Biomed. Anal. 2014, 92:74-81.
51. Yu M.K., Park J., Jon S. Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2012, 2(1):3.
52. Zhou Y., Andersson O., Lindberg P., Liedberg B. Reversible hydrophobic barriers introduced by microcontact printing: application to protein microarrays. Microchim. Acta 2004, 146(3-4):193-205.
53. Wu R.H., Nguyen T.P., Marquart G.W., Miesen T.J., Mau T., Mackiewicz M.R. A facile route to tailoring peptide-stabilized gold nanoparticles using glutathione as a synthon. Molecules 2014, 19(5):6754-6775.
54. Liao H., Hafner J.H. Gold nanorod bioconjugates. Chem. Mater. 2005, 17(18):4636-4641.
55. Loo C., Hirsch L., Lee M.-H., Chang E., West J., Halas N., et al. Gold nanoshell bioconjugates for molecular imaging in living cells. Opt. Lett. 2005, 30(9):1012-1014.
56. Chen J., Saeki F., Wiley B.J., Cang H., Cobb M.J., Li Z.-Y., et al. Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents. Nano Lett. 2005, 5(3):473-477.
57. Singh V., Nair S., Aradhyam G.K. Chemistry of conjugation to gold nanoparticles affects G-protein activity differently. J. Nanobiotechnol. 2013, 11(7).
58. Di Pasqua A.J., Mishler R.E., Ship Y.-L., Dabrowiak J.C., Asefa T. Preparation of antibody-conjugated gold nanoparticles. Mater. Lett. 2009, 63(21):1876-1879.
59. Dam D.H.M., Lee H., Lee R.C., Kim K.H., Kelleher N.L., Odom T.W. Tunable loading of oligonucleotides with secondary structure on gold nanoparticles through a pH-driven method. Bioconjug. Chem. 2015, 26(2):279-285.
60. García Fernández L., Puntes F., Boix B.E. Introducing Gold Nanoparticle Bioconjugates within the Biological Machinery 2013.
61. Schroedter A., Weller H. Ligand design and bioconjugation of colloidal gold nanoparticles. Angew. Chem. Int. Ed. 2002, 41(17):3218-3221.
62. Ke S., Wright J.C., Kwon G.S. Intermolecular interaction of avidin and PEGylated biotin. Bioconjug. Chem. 2007, 18(6):2109-2114.
63. Hirsch J.D., Eslamizar L., Filanoski B.J., Malekzadeh N., Haugland R.P., Beechem J.M., et al. Easily reversible desthiobiotin binding to streptavidin, avidin, and other biotin-binding proteins: uses for protein labeling, detection, and isolation. Anal. Biochem. 2002, 308(2):343-357.
64. Ryvolova M., Chomoucka J., Janu L., Drbohlavova J., Adam V., Hubalek J., et al. Biotin-modified glutathione as a functionalized coating for bioconjugation of CdTe-based quantum dots. Electrophoresis 2011, 32(13):1619-1622.
65. Aćimović S.S., Ortega M.A., Sanz V., Berthelot J., Garcia-Cordero J.L., Renger J., et al. LSPR chip for parallel, rapid, and sensitive detection of cancer markers in serum. Nano Lett. 2014, 14(5):2636-2641.
66. Dykman L.A., Bogatyrev V.A., Khlebtsov B.N., Khlebtsov N.G. A protein assay based on colloidal gold conjugates with trypsin. Anal. Biochem. 2005, 341(1):16-21.
67. Leuvering J.H., Thal P., Waart M., Schuurs A. Sol particle immunoassay (SPIA). J. Immunoass. 1980, 1(1):77-91.
68. Wang J.-H., Wang B., Liu Q., Li Q., Huang H., Song L., et al. Bimodal optical diagnostics of oral cancer based on rose Bengal conjugated gold nanorod platform. Biomaterials 2013, 34(17):4274-4283.
69. Jans H., Liu X., Austin L., Maes G., Huo Q. Dynamic light scattering as a powerful tool for gold nanoparticle bioconjugation and biomolecular binding studies. Anal. Chem. 2009, 81(22):9425-9432.
70. Tessmer I., Kaur P., Lin J., Wang H. Investigating bioconjugation by atomic force microscopy. J. Nanobiotechnol. 2013, 11:25.
71. Wangoo N., Bhasin K., Mehta S., Suri C.R. Synthesis and capping of water-dispersed gold nanoparticles by an amino acid: bioconjugation and binding studies. J. Colloid Interface Sci. 2008, 323(2):247-254.